Welcome to CDC stacks | Clinical Recovery and Circulating Botulinum Toxin Type F in Adult Patient - 3178 | CDC Public Access | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Clinical Recovery and Circulating Botulinum Toxin Type F in Adult Patient
  • Published Date:
    Jun 2009
  • Source:
    Emerg Infect Dis. 15(6):969-971.
Filetype[PDF-436.37 KB]


Details:
No Related Documents.
You May Also Like:
  1. Asymmetric Type F Botulism with Cranial Nerve Demyelination
    Personal Author:
    Filozov, Alina; Kattan, Jessica A.; Jitendranath, Lavanya; Smith, C. Gregory; Lúquez, Carolina; Phan, Quyen N.; Fagan, Ryan P.;
    Published:
    Jan 2012
    Source:
    Emerg Infect Dis. 18(1):102-104.
    Description:
    We report a case of type F botulism in a patient with bilateral but asymmetric neurologic deficits. Cranial nerve demyelination was found during autopsy. Bilateral, asymmetric clinical signs, although rare, do not rule out botulism. Demyelination of ...
    File Type:
    Filetype[PDF - 311.39 KB]
  2. Botulism in Alaska; a guide for physicians and health care providers, 2005 update
    Personal Author:
    Castrodale, Louisa
    Corporate Author:
    Alaska, Division of Public Health., Section of Epidemiology.; Alaska Area Native Health Service.; Centers for Disease Control and Prevention (U.S.), Arctic Investigations Program.;
    Published:
    September 2005
    Description:
    "The Alaska Division of Public Health, the Arctic Investigations Program of the U.S. Centers for Disease Control and Prevention and the Alaska Area Native Health Service of the U.S. Indian Health Service first produced this monograph in 1993 to give ...
    File Type:
    Filetype[PDF - 2.70 MB]
  3. Botulism in the United States, 1899-1996; handbook for epidemiologists, clinicians, and laboratory workers
    Corporate Author:
    National Center for Infectious Diseases (U.S.), Division of Bacterial and Mycotic Diseases.
    Published:
    1998
    Description:
    This report, which updates handbooks issued in 1969, 1973, and 1979, reviews the epidemiology of botulism in the United States since 1899, the problems of clinical and laboratory diagnosis, and the current concepts of treatment. It was written in res...
    File Type:
    Filetype[PDF - 505.40 KB]
  4. Coming Soon
    Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin
    Personal Author:
    Yu, Patricia A.; Lin, Neal H.; Mahon, Barbara E.; Sobel, Jeremy; Yu, Yon; Mody, Rajal K.; Gu, Weidong; Clements, Jennifer; Kim, Hye-Joo; Rao, Agam K.;
    Published:
    Dec 27 2017
    Source:
    Clin Infect Dis. 66(Suppl 1):S57-S64.
    Description:
    Background : Botulism is a rare, life-threatening paralytic illness. Equine-derived heptavalent botulinum antitoxin (HBAT), the only currently available treatment for noninfant botulism in the United States, was licensed in 2013. No reports have syst...
    Public Access
    Available on:
    December 27, 2018
  5. National Enteric Disease Surveillance : botulism surveillance overview
    Corporate Author:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne Waterborne, and Environmental Diseases.; Council of State and Territorial Epidemiologists.;
    Published:
    March 2012
    Description:
    Surveillance System Overview: National Botulism Surveillance System. : Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium Clostridium botulinum and sometimes by strains of Clostridium butyricum ...
    File Type:
    Filetype[PDF - 565.49 KB]